Innospec Inc.
IOSPBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeInnospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. With a market capitalization of $2.31B, it sits in mid-cap territory. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
Market Cap
$2.31B
Beta
0.92
P/E (TTM)
19.17
P/E (Fwd)
15.28
EPS (TTM)
$4.90
EPS (Fwd)
$6.15
ROE
9.1%
ROA
5.1%
Cash
$250.2M
Total Debt
$47.9M
Free CF
$32.6M
52W Change
12.4%
Annual Financials
Cash vs Debt
Where IOSP stands vs its 150-day and 200-day moving averages
As of the August 27, 2026 close, IOSP finished 19.01% above its 150-day moving average ($80.38) and 20.78% above its 200-day moving average ($79.20). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IOSP overbought or oversold?
At the August 27, 2026 close, IOSP's RSI(14) was 73.0, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $250.2M in cash and $47.9M in debt, IOSP maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $32.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 9.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.96B (2022) to $1.78B (2025).
With cash comfortably exceeding debt, IOSP has financial flexibility that may help navigate uncertain periods. No single metric tells the full story. Reviewing IOSP's risk profile alongside its fundamentals and technical indicators provides a more complete picture.